Are a GI Specialist Treating Patients Remotely Due to COVID-19


Remote Testing for Your Patients

If You Are a GI Specialist Treating Patients Remotely Due to COVID-19, This Information May Be Helpful

Do you have patients who are suffering with unresolved IBS-like symptoms including gas, bloating, diarrhea, and/or nausea? Have you considered Sucrose Intolerance due to Congenital Sucrase-Isomaltase Deficiency (CSID)? A 13C-Sucrose Breath Test can help you rule out CSID, and the entire test can be performed remotely.

Order Free* Breath Test Kits for Your Office

Order Free* Breath Test Kits for Your Office

The 13C-Sucrose Breath Test is designed to help diagnose patients who are suffering with IBS-like symptoms that may actually be due to CSID (Congenital Sucrase-Isomaltase Deficiency). The test can be ordered by fax or phone and shipped directly to your patient.

  • Your patient takes the test in the comfort of their home and then drops the completed kit in the mail for analysis. Shipping and handling are included so there is no need for your patient to leave their home.
  • The results are sent to you for your evaluation and review with your patient. It’s that simple.
  • THE TEST IS FREE. There is no charge to you or your patient. The test is sponsored by QOL Medical, LLC, maker of Sucraid®. Sucraid® Treats CSID.

Call to Order FREE* Sucrose Breath Test Kits for Your Patients

1-833-444-2743 (CSID)

*Breath tests are provided at no charge and are not billed to the patient or any third party payor.

Important Safety Information for Sucraid® (sacrosidase) Oral Solution

  • Sucraid® may cause a serious allergic reaction. Patients should stop taking Sucraid® and get emergency help immediately if any of the following side effects occur: difficulty breathing, wheezing, or swelling of the face. Care should be taken when administering initial doses of Sucraid® to observe any signs of acute hypersensitivity reaction.
  • Do not use Sucraid® (sacrosidase) Oral Solution with patients known to be hypersensitive to yeast, yeast products, papain, or glycerin (glycerol).
  • Although Sucraid® provides replacement therapy for the deficient sucrase, it does not provide specific replacement therapy for the deficient isomaltase.
  • Adverse reactions as a result of taking Sucraid® may include worse abdominal pain, vomiting, nausea, diarrhea, constipation, difficulty sleeping, headache, nervousness, and dehydration.
  • Before prescribing Sucraid® to diabetic patients, the physician should consider that Sucraid® will enable sucrose hydrolysis and the absorption of those hydrolysis products, glucose and fructose.
  • The effects of Sucraid® have not been evaluated in patients with secondary (acquired) disaccharidase deficiency.
  • DO NOT HEAT SOLUTIONS CONTAINING SUCRAID®. Do not put Sucraid® in warm or hot fluids. Do not reconstitute or consume Sucraid® with fruit juice since the acidity of the juice may reduce the enzyme activity of Sucraid®. Half of the reconstituted Sucraid® should be taken at the beginning of the meal or snack and the other half during the meal or snack.
  • Sucraid® should be refrigerated at 36°F-46°F (2°C-8°C) and should be protected from heat and light.


Sucraid®(sacrosidase) Oral Solution is an enzyme replacement therapy for the treatment of genetically determined sucrase deficiency, which is part of Congenital Sucrase-Isomaltase Deficiency (CSID).